A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers' reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide.
A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers’ reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide. Such changes alarm providers in the aftermath of other funding reductions that have affected Medicare, including the government sequestrian, and other mandates associated with health reform. The recommendations are part of adjustments to the end-stage renal disease (ESRD) program.
“This is a very dramatic cut," Robert Sepucha, Senior VP, Policy and Business Development at Fresenius Medical Care, said. “We’re concerned it would push dialysis clinics under the cost of care, which is not the right thing for Medicare to be doing.”
Recent estimates show that 85% of American dialysis patients rely on Medicare to receive kidney disease treatment. The CMS cuts would affect almost half a million Americans, threating the quality of care for some of the most sickly and vulnerable patients. An additional 20 million of those affected are at increased risk of ESRD due to health and genetic factors and may require dialysis in the future.
Heather Dauler, Director of Government Affairs at Satellite Healthcare, said communities rely on providers like the Satellite clinic to provide high quality care in an accessible way. “While we will continue to strive to meet these needs, the extent of the proposed cuts may compromise our ability to do so,” Ms Dauler commented.
Medicare had already faced difficulties in covering costs for many ESRD patients, even before the sequestrian effects.
"Dialysis providers are struggling to absorb and adjust to the other Medicare cuts made to the program in recent years," said Ron Kuerbitz, Chair of Kidney Care Partners. "The current proposal is untenable, and would dramatically underfund this crucial therapy for Medicare beneficiaries on dialysis. To protect the well-being of our patients, CMS must ensure that Medicare reimbursement is adequate to cover the cost of providing quality care.”
The CMS proposal remains open to public comment until August 30.
Around the Web
DaVita Among Dialysis Outlets Facing 9.4% Medicare Cut [Bloomberg]
Proposed Medicare Cuts Have Broad Implications For Dialysis Services Offerings [Herald Online]
Nation's Kidney Community Deeply Concerned Over Government's "Untenable" Proposed Cut to the Nation's Medicare's Dialysis Program
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen